Harvard Bioscience, Inc. (HBIO)
7.93
+0.03
(+0.38%)
USD |
NASDAQ |
Aug 28, 16:00
7.98
+0.05
(+0.63%)
After-Hours: 20:00
Harvard Bioscience Cash from Operations (Quarterly) : 0.323M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.323M |
| March 31, 2026 | -0.791M |
| December 31, 2025 | 0.591M |
| September 30, 2025 | 0.83M |
| June 30, 2025 | 2.451M |
| March 31, 2025 | 2.857M |
| December 31, 2024 | 1.725M |
| September 30, 2024 | -0.842M |
| June 30, 2024 | -0.846M |
| March 31, 2024 | 1.403M |
| December 31, 2023 | 4.303M |
| September 30, 2023 | 4.361M |
| June 30, 2023 | 3.552M |
| March 31, 2023 | 1.812M |
| December 31, 2022 | 2.679M |
| September 30, 2022 | 0.649M |
| June 30, 2022 | -0.19M |
| March 31, 2022 | -1.986M |
| December 31, 2021 | 0.117M |
| September 30, 2021 | -0.558M |
| June 30, 2021 | 0.666M |
| March 31, 2021 | 1.037M |
| December 31, 2020 | 2.49M |
| September 30, 2020 | 1.597M |
| June 30, 2020 | 2.373M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.871M |
| December 31, 2019 | 2.22M |
| September 30, 2019 | 3.158M |
| June 30, 2019 | 0.657M |
| March 31, 2019 | 2.01M |
| December 31, 2018 | 2.593M |
| September 30, 2018 | -1.434M |
| June 30, 2018 | 1.277M |
| March 31, 2018 | 0.448M |
| December 31, 2017 | -0.939M |
| September 30, 2017 | 2.131M |
| June 30, 2017 | 0.475M |
| March 31, 2017 | -0.61M |
| December 31, 2016 | 1.727M |
| September 30, 2016 | 3.44M |
| June 30, 2016 | 0.942M |
| March 31, 2016 | -0.726M |
| December 31, 2015 | 1.764M |
| September 30, 2015 | -0.078M |
| June 30, 2015 | -0.484M |
| March 31, 2015 | -0.497M |
| December 31, 2014 | 1.263M |
| September 30, 2014 | 0.602M |
| June 30, 2014 | 1.414M |
| March 31, 2014 | 1.072M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 98.70M |
| Bruker Corp. | -77.40M |
| Danaher Corp. | 1.534B |
| Illumina, Inc. | 201.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.916M |
| Cash from Financing (Quarterly) | -0.036M |
| Free Cash Flow | -1.53M |
| Free Cash Flow Per Share (Quarterly) | -0.131 |
| Free Cash Flow to Equity (Quarterly) | -0.677M |
| Free Cash Flow to Firm (Quarterly) | 1.209M |
| Free Cash Flow Yield | -4.31% |